139 related articles for article (PubMed ID: 2116232)
1. Modulation of the cell-mediated immune function by interferon alpha, beta or gamma can partially reverse the immunosuppression induced by human T-cell leukemia virus I in human cord blood cultures.
D'Onofrio C; Pesce CD; Fontana T; Ciprani F; Bonmassar E; Caliŏ R
Cancer Immunol Immunother; 1990; 31(4):213-20. PubMed ID: 2116232
[TBL] [Abstract][Full Text] [Related]
2. Combined treatments with interferon (alpha,beta) plus PGA1 to control early infection with HTLV-I in primary cord blood-derived mononuclear cells.
D'Onofrio C; Franzese O; Ricci F; Bonmassar E
Int J Immunopharmacol; 1993 Feb; 15(2):125-36. PubMed ID: 8468116
[TBL] [Abstract][Full Text] [Related]
3. Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon.
D'Onofrio C; Perno CF; Mazzetti P; Graziani G; Calio' R; Bonmassar E
Br J Cancer; 1988 May; 57(5):481-8. PubMed ID: 2899440
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of individual versus combined treatments with interferon alpha, beta and gamma on early infection with HTLV-I in vitro.
D'Onofrio C; Franzese O; Puglianiello A; Peci E; Lanzilli G; Bonmassar E
Int J Immunopharmacol; 1992 Aug; 14(6):1069-79. PubMed ID: 1428362
[TBL] [Abstract][Full Text] [Related]
5. Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures.
D'Onofrio C; Alvino E; Garaci E; Bonmassar E; Santoro MG
Br J Cancer; 1990 Feb; 61(2):207-14. PubMed ID: 2310673
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological consequences of human T cell leukemia virus type-I and Schistosoma mansoni co-infection.
Santos SB; Porto AF; Muniz AL; Jesus AR; Carvalho EM
Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):121-6. PubMed ID: 15486648
[TBL] [Abstract][Full Text] [Related]
7. Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-I.
Macchi B; D'Onofrio C; Labianca RA; Bonmassar E
Pharmacol Res; 1990; 22(4):503-14. PubMed ID: 2205849
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors.
Carvalho EM; Bacellar O; Porto AF; Braga S; Galvão-Castro B; Neva F
J Acquir Immune Defic Syndr; 2001 May; 27(1):1-6. PubMed ID: 11404513
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood.
Macchi B; Faraoni I; Mastino A; D'Onofrio C; Romeo G; Bonmassar E
Cancer Immunol Immunother; 1993 Jul; 37(2):97-104. PubMed ID: 8100486
[TBL] [Abstract][Full Text] [Related]
10. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
McGinn TM; Wei Q; Stallworth J; Fultz PN
AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
[TBL] [Abstract][Full Text] [Related]
11. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
[TBL] [Abstract][Full Text] [Related]
12. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
[TBL] [Abstract][Full Text] [Related]
13. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression.
Yamamoto-Taguchi N; Satou Y; Miyazato P; Ohshima K; Nakagawa M; Katagiri K; Kinashi T; Matsuoka M
PLoS Pathog; 2013 Sep; 9(9):e1003630. PubMed ID: 24068936
[TBL] [Abstract][Full Text] [Related]
14. Modulation of T-cell responses to a recall antigen in human T-cell leukemia virus type 1-infected individuals.
Suzuki M; Dezzutti CS; Okayama A; Tachibana N; Tsubouchi H; Mueller N; Lal RB
Clin Diagn Lab Immunol; 1999 Sep; 6(5):713-7. PubMed ID: 10473523
[TBL] [Abstract][Full Text] [Related]
15. Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III.
Dolei A; Fattorossi A; D'Amelio R; Aiuti F; Dianzani F
J Interferon Res; 1986 Oct; 6(5):543-9. PubMed ID: 3100665
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.
Mascarenhas RE; Brodskyn C; Barbosa G; Clarêncio J; Andrade-Filho AS; Figueiroa F; Galvão-Castro B; Grassi F
Clin Vaccine Immunol; 2006 May; 13(5):547-52. PubMed ID: 16682474
[TBL] [Abstract][Full Text] [Related]
17. Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia virus type I and HIV-1.
Nyland SB; Cao C; Bai Y; Loughran TP; Ugen KE
J Acquir Immune Defic Syndr; 2003 Apr; 32(4):406-16. PubMed ID: 12640199
[TBL] [Abstract][Full Text] [Related]
18. HTLV-I-infected T cells evade the antiproliferative action of IFN-beta.
Smith D; Buckle GJ; Hafler DA; Frank DA; Höllsberg P
Virology; 1999 May; 257(2):314-21. PubMed ID: 10329542
[TBL] [Abstract][Full Text] [Related]
19. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.
Kinpara S; Hasegawa A; Utsunomiya A; Nishitsuji H; Furukawa H; Masuda T; Kannagi M
J Virol; 2009 May; 83(10):5101-8. PubMed ID: 19264779
[TBL] [Abstract][Full Text] [Related]
20. Antiviral and antiproliferative activities of recombinant human interferon alpha 2, beta and gamma on HTLV-I and ATL cells in vitro.
Koyama Y; Tanaka Y; Oda S; Yamashita U; Eto S
J UOEH; 1990 Jun; 12(2):149-61. PubMed ID: 2117774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
